Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel pseudogene KIAA2013 (also known as LOC728138) is a processed pseudogene located in the human genome with high sequence homology to the protein-coding KIAA2013 gene[3][5]. Processed pseudogenes arise from reverse transcription of mRNA and reinsertion into the genome, lacking introns and frequently rendered nonfunctional due to mutations in coding or regulatory sequences[2][4]. The KIAA2013 functional gene encodes a transmembrane protein of unknown function, but its pseudogene counterpart is not known to produce a functional protein and does not act as a druggable therapeutic target[5][3]. Although some pseudogenes can exert regulatory functions at the RNA level (such as acting as miRNA decoys or influencing parental gene expression), there is no evidence that LOC728138 is itself a functional regulator or involved in therapeutically relevant pathways for disease or drug interaction[1][6]. No drugs, biomarkers, or direct mechanism-of-action data are associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel pseudogene KIAA2013.